dr. sara m. tolaney on neoadjuvant treatment considerations for tnbc
Published 9 years ago • 195 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:09
sara m. tolaney on neoadjuvant treatment considerations for triple-negative breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:32
dr tolaney on data with checkpoint inhibitor combinations in metastatic tnbc
-
1:25
dr. tolaney on neoadjuvant her2-directed therapy
-
12:47
neoadjuvant treatment in triple-negative breast cancer
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
1:13
dr. tolaney discusses patient selection for platinum-based therapy in tnbc
-
13:10
expert perspectives in the management of triple-negative breast cancer with sara tolaney, md, mph
-
18:29
new frontiers in triple negative breast cancer
-
3:39
her2-positive
-
1:30:38
triple-negative breast cancer 360: waiting for the future webcast
-
0:52
dr. yee on neoadjuvant therapy for triple-negative breast cancer
-
2:00
dr sara m. tolaney: challenges with treating, role of clinical trials in her2-positive breast cancer
-
7:37
dr. tolaney highlights new breast cancer combination therapies
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
3:06
dr. sara tolaney on adjuvant cisplatin and radiation for triple-negative breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
3:26
dr. sara tolaney on eribulin plus pembrolizumab for metastatic triple-negative breast cancer
-
1:53
dr. chagpar on novel agents for neoadjuvant tnbc treatment
-
0:57
dr. tolaney on trials investigating cabozantinib in breast cancer